Hundreds of generics face European ban following GVK breaches
This article was originally published in Scrip
Executive Summary
Several hundred generic medicines look set to have their marketing authorizations suspended in Europe following an investigation by the European Medicines Agency after the French medicines agency ANSM uncovered data manipulation by the Indian contract research organization GVK Biosciences.